Ethyl 5-chloroisoxazole-3-carboxylate

Catalog No. :
ACTBCS952
CAS No. :
343566-56-3
Molecular Formula :
C6H6ClNO3
Molecular Weight :
175.57

IUPAC Name:ethyl 5-chloroisoxazole-3-carboxylate

Ethyl 5-chloroisoxazole-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$95.00Login to see priceIn stockInquiry
250mg97%$161.00Login to see priceIn stockInquiry
1g97%$477.00Login to see priceIn stockInquiry
5g97%$2290.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 5-chloroisoxazole-3-carboxylate
IUPAC Nameethyl 5-chloroisoxazole-3-carboxylate
MDL No.MFCD16547333
Molecular FormulaC6H6ClNO3
Molecular Weight175.57
SMILESO=C(C1=NOC(Cl)=C1)OCC
InChI KeyNXEVNGXFHGZHPC-UHFFFAOYSA-N
Synonym5-Chloro-isoxazole-3-carboxylic acid ethyl ester;ethyl 5-chloro-1,2-oxazole-3-carboxylate;Ethyl 5-chloroisoxazole-3-carboxylate;3-Isoxazolecarboxylic acid, 5-chloro-, ethyl ester
CAS No.343566-56-3
PubChem CID66831968

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTBCS952 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFNAI078 route compound structure diagram
    ACFNAI07815715-58-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTBCS952 route product structure diagram
    ACTBCS952343566-56-3 In Stock
Inquiry

2. ACTBCS952 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFNAI078 route compound structure diagram
    ACFNAI07815715-58-9 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACTBCS952 route product structure diagram
    ACTBCS952343566-56-3 In Stock
Inquiry

Comments (0)